Results 101 to 110 of about 93,843 (327)

Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease

Hepatology Research, EarlyView.
ABSTRACT Aims Elevated serum free light chain (FLC) and B‐cell activating factor (BAFF) levels have been reported to be associated with B‐cell activation and to serve as biomarkers reflecting disease severity in various diseases. However, limited investigation has been conducted in the context of chronic liver disease (CLD), and the aim of this study ...
Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Hideaki Tanaka, Ryo Nakagawa, Mina Tempaku, Yoshinao Kobayashi, Hayato Nakagawa   +8 more
wiley   +1 more source

Evidenciação de antígeno da hepatite B (HBsAg) em "manchas" obtidas de exemplares de Triatominae: nota prévia [PDF]

, 1976
J. A. N. Candeias, Oswaldo Paulo Forattini, José Gilberto H. Vieira   +2 more
openalex   +1 more source

Prognostic Significance of Bile Duct Loss in Early‐Stage Primary Biliary Cholangitis: A Long‐Term Observational Study

Hepatology Research, EarlyView.
Bile duct loss on liver biopsy predicts future liver‐related events in early‐stage primary biliary cholangitis, even in patients with preserved liver function. This finding highlights the prognostic value of histological bile duct assessment at diagnosis and may guide early risk stratification and management decisions.
Taiki Okumura, Takefumi Kimura, Takanobu Iwadare, Shun‐Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Satoru Joshita, Michiharu Komatsu, Naoki Tanaka, Akihiro Matsumoto, Tomoyuki Nakajima, Mai Iwaya, Masahiro Umemura, Kazuhito Kawata, Kenichi Harada, Takeji Umemura   +15 more
wiley   +1 more source

Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant

Pharmaceutical Biology, 2019
Context: The co-delivery of adjuvant and antigen has shown to be more effective for targeting the immune response than antigen alone. Therefore, designing an efficient bicistronic system is more assuring for production of both elements in the same ...
Sara Mohammadzadeh, Hamideh Ofoghi, Mina Ebrahimi-Rad, Parastoo Ehsani   +3 more
doaj   +1 more source

Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study

Hepatology Research, EarlyView.
ABSTRACT Aim This study is aimed to evaluate the safety and outcomes of surgical resection in patients with hepatocellular carcinoma (HCC) treated with systemic therapy, address the therapeutic benefit, and identify candidates for surgery after systemic treatment.
Takamichi Ishii, Junichi Shindoh, Ikuo Nakamura, Seiko Hirono, Masaki Wakasugi, Akihiko Ichida, Takashi Hamada, Hajime Matsushima, Takahiro Nishio, Yukio Tokumitsu, Hidenori Takahashi, Yuji Morine, Shinichiro Yamada, Akiyoshi Nakakura, Susumu Eguchi, Kiyoshi Hasegawa, Etsuro Hatano   +16 more
wiley   +1 more source

Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. [PDF]

, 1976
Mukunda B. Ray, Valeer Desmet, Johan Fevery, J. De Groote, A F Bradburne, Jan Desmyter   +5 more
openalex   +1 more source

Combined screening of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in an emergency department: The URDEPTRIO cross‐sectional study

Academic Emergency Medicine, EarlyView.
Chris Wong, Quentin Le Hingrat, Florian Salipante, Vincent Mackiewicz, Florence Damond, Lucile Larrouy, Christophe Choquet, Dan Pospai, Karen Champenois, Diane Descamps, Judith Leblanc, Paul Loubet, Enrique Casalino, Jade Ghosn, Donia Bouzid   +14 more
wiley   +1 more source

Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature review of clinical and patient‐reported outcomes

HIV Medicine, EarlyView.
Abstract Background Treatment guidelines recommend rapid antiretroviral therapy (ART) initiation among eligible people with HIV to improve treatment outcomes and reduce HIV transmission. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), an integrase strand transfer inhibitor‐based single‐tablet regimen, is recommended for rapid start in US and
Jade Ghosn, Jeremy Chow, Monica Gandhi, Miguel Górgolas, Aws Al‐Hayani, Hansel Tookes, Max Lee, Emily F. Kaiser, David Malebranche, Fernando Alvarez Bognar, Bhumi Gandhi‐Patel, Lili Dai   +11 more
wiley   +1 more source

Characterization of Antibodies to the Structural Polypeptides of HBsAg: Evidence for Subtype-Specific Determinants [PDF]

, 1976
Jon W. M. Gold, J. Wai-Kuo Shih, Robert H. Purcell, John L. Gerin   +3 more
openalex   +1 more source

Metabolic dysfunction‐associated liver disease predicts incident liver fibrosis in people with HIV mono‐infection: A cohort study

HIV Medicine, EarlyView.
Abstract Introduction Metabolic dysfunction‐associated liver disease (MASLD) might progress to cirrhosis. We aimed to evaluate the association of MASLD with the risk of developing clinically significant fibrosis (CSF) in people living with HIV (PLWH).
Juliana Fittipaldi, Sandra W. Cardoso, Estevão Portela Nunes, Cristiane Fonseca De Almeida, Patricia Dias De Brito, Valdilea G. Veloso, Beatriz Grinsztejn, Hugo Perazzo   +7 more
wiley   +1 more source